Inventor · disambiguated record
Markus Gold
Also filed as: GOLD MARKUS · GOLD MARKUS R · GOLD MARKUS-RENE
11 granted patents·5 pending applications·557 citations·filing 1990–2010
91Inventor score
Top patents by PatentIndex Score
16 records- 0196US6034134A1-Amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Mar 7, 2000·238 cites·22 claims
- 0292US5061703AAdamantane derivatives in the prevention and treatment of cerebral ischemiaMERZ & CO GMBH & CO·Filed 1990·Granted Oct 29, 1991·196 cites·13 claims
- 0384US6071966A1-amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Jun 6, 2000·74 cites·12 claims
- 0478US6828462B2Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2002·Granted Dec 7, 2004·14 cites·9 claims
- 0566US6602862B11-Amino-alkylcyclohexanes as trypanocidal agentsMERZ PHARMA GMBH & CO KGAA·Filed 2000·Granted Aug 5, 2003·3 cites·16 claims
- 0662US7022729B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2003·Granted Apr 4, 2006·1 cites·3 claims
- 0761US8796491B2Process for manufacturing adamantane derivatives with high yieldGOLD MARKUS-RENE·Filed 2009·Granted Aug 5, 2014·1 cites·13 claims
- 0861US5776935APyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmissionMERZ & CO GMBH & CO·Filed 1996·Granted Jul 7, 1998·22 cites·12 claims
- 0956US2007185151A1Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Application pending·0 cites
- 1055US7238703B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Jul 3, 2007·0 cites·3 claims
- 1153US2007105961A11-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2006·Application pending·0 cites
- 1245US2011288336A1Method for producing memantineGOLD MARKUS-RENE·Filed 2009·Application pending·0 cites
- 1343US2010298442A11-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2010·Application pending·0 cites
- 1441US5254549ANew BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugsMERZ & CO GMBH & CO·Filed 1991·Granted Oct 19, 1993·8 cites·12 claims
- 1540US8692021B2Method of preparing Neramexane or a salt thereofGOLD MARKUS-RENE·Filed 2010·Granted Apr 8, 2014·0 cites·18 claims
- 1636US2011282100A1Process for preparing memantineQUACK GUNTER·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Gold files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →